Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2020 16:45 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Third Quarter 2020 Financial Results

SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
May 11, 2020 08:30 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
May 08, 2020 08:00 ET | Source: Obalon Therapeutics, Inc.

William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director

SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
April 28, 2020 09:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
March 25, 2020 08:30 ET | Source: Obalon Therapeutics, Inc.

Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives

SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
March 17, 2020 17:21 ET | Source: Obalon Therapeutics, Inc.

Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic

SAN DIEGO, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
February 27, 2020 07:31 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Fourth Quarter and Full Year 2019 Financial Results

SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
February 20, 2020 08:15 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
February 13, 2020 09:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time

SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
February 07, 2020 16:15 ET | Source: Obalon Therapeutics, Inc.

Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund

SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...

Next Page keyboard_arrow_right